CytomX Therapeutics (CTMX) Quick Ratio: History & Chart

CytomX Therapeutics, Inc.(CTMX)

Biotechnology · South San Francisco, CA

$2.58+0.00 (+0.18%)

Delayed quote: Oct 6, 2026, 12:54 PM EDT

About CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc. is a United States-based biopharmaceutical company primarily focused on creating treatments for cancer. The company utilizes its proprietary Probody technology platform to engineer targeted antibody therapeutics for oncological applications. Its robust clinical pipeline includes several notable drug candidates. CX-2009, an antibody-drug conjugate (ADC) designed to target CD166, is currently in Phase II clinical trials for treating breast cancer. Another investigational therapy, CX-2029, has also reached Phase II trials, where it is being evaluated for various cancers such as squamous non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal and gastro-esophageal junction cancers, and diffuse large B-cell lymphoma. Additionally, CytomX is progressing two CTLA-4 Probody therapeutics: BMS-986249, which is undergoing Phase I/II clinical trials for metastatic melanoma, and BMS-986288, in Phase I trials for solid tumors. Beyond these, the company is developing CX-2043, a conditionally activated ADC targeting the epithelial cell adhesion molecule, and CX-904, a conditionally activated epidermal growth factor receptor, both aimed at addressing solid tumor conditions. CytomX has forged strategic partnerships with leading pharmaceutical firms, including AbbVie Ireland Unlimited Company, Amgen, Inc., Bristol-Myers Squibb Company, ImmunoGen, Inc., Pfizer Inc., and Astellas Pharma Inc., to collaboratively advance its Probody therapeutics. The company was founded in 2008 and its main office is located in South San Francisco, California.

South San Francisco, CA

69 employees

www.cytomx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Sean A. McCarthy

View full financials

CTMX Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

9.36

QUICK RATIO (ACID-TEST) AVG TTM

6.13

QUICK RATIO (ACID-TEST) AVG 3Y

1.91

QUICK RATIO (ACID-TEST) AVG 5Y

2.12

QUICK RATIO (ACID-TEST) AVG 10Y

3.45

QUICK RATIO (ACID-TEST) AVG 15Y

N/A

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

+52.66%

CURRENT VS 3Y AVG

+391.05%

CURRENT VS 5Y AVG

+342.12%

CURRENT VS 10Y AVG

+171.24%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.20

median of 785 covered companies

CURRENT VS SECTOR MEDIAN

+192.54%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
CytomX Therapeutics, Inc. (CTMX)	$562.70M	9.36	6.13	1.91	2.12
CorMedix Inc. (CRMD)vs ›	$566.03M	2.36	2.55	5.33	7.55
MiniMed Group, Inc. (MMEDV)vs ›	$560.00M	N/A	N/A	N/A	N/A
Aquestive Therapeutics, Inc. (AQST)vs ›	$571.50M	6.74	3.69	2.52	2.35
Nuvectis Pharma, Inc. (NVCT)vs ›	$540.28M	1.68	2.23	2.63	2.59
BlossomHill Therapeutics, Inc. (BLSM)vs ›	$546.14M	5.42	12.18	12.18	12.18
Aclaris Therapeutics, Inc. (ACRS)vs ›	$539.80M	3.46	4.63	6.00	6.13
Phathom Pharmaceuticals, Inc. (PHAT)vs ›	$537.99M	1.87	2.92	5.55	6.22
Delcath Systems, Inc. (DCTH)vs ›	$536.47M	8.95	10.43	5.97	5.34
ProKidney Corp. (PROK)vs ›	$536.32M	8.36	10.03	20.35	14.11

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

CytomX Therapeutics, Inc. (CTMX)

$562.70M

9.36

6.13

1.91

2.12

CorMedix Inc. (CRMD)vs ›

$566.03M

2.36

2.55

5.33

7.55

MiniMed Group, Inc. (MMEDV)vs ›

$560.00M

N/A

Aquestive Therapeutics, Inc. (AQST)vs ›

$571.50M

6.74

3.69

2.52

2.35

Nuvectis Pharma, Inc. (NVCT)vs ›

$540.28M

1.68

2.23

2.63

2.59

BlossomHill Therapeutics, Inc. (BLSM)vs ›

$546.14M

5.42

12.18

Aclaris Therapeutics, Inc. (ACRS)vs ›

$539.80M

3.46

4.63

6.00

6.13

Phathom Pharmaceuticals, Inc. (PHAT)vs ›

$537.99M

1.87

2.92

5.55

6.22

Delcath Systems, Inc. (DCTH)vs ›

$536.47M

8.95

10.43

5.97

5.34

ProKidney Corp. (PROK)vs ›

$536.32M

8.36

10.03

20.35

14.11

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for CytomX Therapeutics, Inc. (CTMX)?

The quick ratio (acid-test) for CTMX stock is 9.36.

Is CytomX Therapeutics, Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 9.36 is 342% above its 5-year average of 2.12, near the high end of its 5-year range (1.00–10.38).

What is the TTM average quick ratio (acid-test) for CytomX Therapeutics, Inc. (CTMX)?

The TTM average quick ratio (acid-test) for CTMX stock is 6.13.

What is the 3Y average quick ratio (acid-test) for CytomX Therapeutics, Inc. (CTMX)?

The 3Y average quick ratio (acid-test) for CTMX stock is 1.91.

What is the 5Y average quick ratio (acid-test) for CytomX Therapeutics, Inc. (CTMX)?

The 5Y average quick ratio (acid-test) for CTMX stock is 2.12.

What is the 10Y average quick ratio (acid-test) for CytomX Therapeutics, Inc. (CTMX)?

The 10Y average quick ratio (acid-test) for CTMX stock is 3.45.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	9.36
2026-03-31	10.38
2025-12-31	3.09
2025-09-30	3.64
2025-06-30	4.20
2025-03-31	1.73
2024-12-31	1.25
2024-09-30	1.04
2024-06-30	1.00
2024-03-31	1.16
2023-12-31	1.17
2023-09-30	1.37
2023-06-30	1.33
2023-03-31	1.40
2022-12-31	1.55
2022-09-30	2.05
2022-06-30	2.34
2022-03-31	2.61
2021-12-31	3.98
2021-09-30	2.42
2021-06-30	2.90
2021-03-31	4.08
2020-12-31	4.76
2020-09-30	3.34
2020-06-30	3.71
2020-03-31	3.77
2019-12-31	3.54
2019-09-30	4.40
2019-06-30	4.66
2019-03-31	4.21
2018-12-31	4.55
2018-09-30	5.48
2018-06-30	4.41
2018-03-31	5.27
2017-12-31	6.36
2017-09-30	5.28
2017-06-30	5.62
2017-03-31	4.50
2016-12-31	5.26
2016-09-30	7.74
2016-06-30	8.98
2016-03-31	10.85
2015-12-31	12.06
2015-09-30	8.23
2015-06-30	11.63
2015-03-31	5.78
2014-12-31	5.98
2014-09-30	0.00
2014-06-30	0.00
2014-03-31	0.00

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

9.36

2026-03-31

10.38

2025-12-31

3.09

2025-09-30

3.64

2025-06-30

4.20

2025-03-31

1.73

2024-12-31

1.25

2024-09-30

1.04

2024-06-30

1.00

2024-03-31

1.16

2023-12-31

1.17

2023-09-30

1.37

2023-06-30

1.33

2023-03-31

1.40

2022-12-31

1.55

2022-09-30

2.05

2022-06-30

2.34

2022-03-31

2.61

2021-12-31

3.98

2021-09-30

2.42

2021-06-30

2.90

2021-03-31

4.08

2020-12-31

4.76

2020-09-30

3.34

2020-06-30

3.71

2020-03-31

3.77

2019-12-31

3.54

2019-09-30

4.40

2019-06-30

4.66

2019-03-31

4.21

2018-12-31

4.55

2018-09-30

5.48

2018-06-30

4.41

2018-03-31

5.27

2017-12-31

6.36

2017-09-30

5.28

2017-06-30

5.62

2017-03-31

4.50

2016-12-31

5.26

2016-09-30

7.74

2016-06-30

8.98

2016-03-31

10.85

2015-12-31

12.06

2015-09-30

8.23

2015-06-30

11.63

2015-03-31

5.78

2014-12-31

5.98

2014-09-30

0.00

2014-06-30

0.00

2014-03-31

0.00

Quick Ratio (Acid-Test): 9.36

CTMX Quick Ratio

CTMX Average Quick Ratio (Acid-Test) Chart

CTMX Current vs Average Quick Ratio (Acid-Test) Chart

CTMX Quick Ratio (Acid-Test) Metrics

CTMX Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

CTMX Quick Ratio (Acid-Test) History

Related Metrics